JP2018524361A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018524361A5 JP2018524361A5 JP2018500814A JP2018500814A JP2018524361A5 JP 2018524361 A5 JP2018524361 A5 JP 2018524361A5 JP 2018500814 A JP2018500814 A JP 2018500814A JP 2018500814 A JP2018500814 A JP 2018500814A JP 2018524361 A5 JP2018524361 A5 JP 2018524361A5
- Authority
- JP
- Japan
- Prior art keywords
- human
- antibody
- amino acid
- seq
- inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021142739A JP7366093B2 (ja) | 2015-07-14 | 2021-09-01 | 抗体と併用投与されるｉｄｏ阻害剤含有腫瘍治療剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562192173P | 2015-07-14 | 2015-07-14 | |
| US62/192,173 | 2015-07-14 | ||
| PCT/JP2016/003337 WO2017010106A1 (en) | 2015-07-14 | 2016-07-14 | A therapeutic agent for a tumor comprising an ido inhibitor administered in combination with an antibody |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021142739A Division JP7366093B2 (ja) | 2015-07-14 | 2021-09-01 | 抗体と併用投与されるｉｄｏ阻害剤含有腫瘍治療剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018524361A JP2018524361A (ja) | 2018-08-30 |
| JP2018524361A5 true JP2018524361A5 (enExample) | 2019-08-08 |
Family
ID=57757291
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018500814A Ceased JP2018524361A (ja) | 2015-07-14 | 2016-07-14 | 抗体と併用投与されるｉｄｏ阻害剤含有腫瘍治療剤 |
| JP2021142739A Active JP7366093B2 (ja) | 2015-07-14 | 2021-09-01 | 抗体と併用投与されるｉｄｏ阻害剤含有腫瘍治療剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021142739A Active JP7366093B2 (ja) | 2015-07-14 | 2021-09-01 | 抗体と併用投与されるｉｄｏ阻害剤含有腫瘍治療剤 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20180271861A1 (enExample) |
| EP (2) | EP3991749A3 (enExample) |
| JP (2) | JP2018524361A (enExample) |
| KR (1) | KR102823683B1 (enExample) |
| CN (1) | CN107847597A (enExample) |
| AU (1) | AU2016293667A1 (enExample) |
| CA (1) | CA2992238A1 (enExample) |
| HK (1) | HK1252514A1 (enExample) |
| TW (1) | TW201713332A (enExample) |
| WO (1) | WO2017010106A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2021500916A (ja) | 2017-07-28 | 2021-01-14 | フェインズ セラピューティクス，インコーポレーテッド | 抗ｔｉｍ−３抗体及びその使用 |
| MX2021002302A (es) * | 2018-08-29 | 2021-04-28 | Chemocentryx Inc | Terapia de combinacion usando antagonistas de receptor de quimiocina c-c 4 (ccr4) y uno o mas inhibidores de punto de control. |
| US11839659B2 (en) | 2020-07-02 | 2023-12-12 | Northwestern University | Proteolysis-targeting chimeric molecules (PROTACs) that induce degradation of indoleamine 2,3-dioxygenase (IDO) protein |
| CN112961239B (zh) * | 2021-02-24 | 2021-09-10 | 北京昭衍生物技术有限公司 | Tim抑制剂及其应用 |
| BR112023017582A2 (pt) | 2021-03-05 | 2023-12-05 | Univ Basel | Composições para o tratamento de doenças ou condições associadas ao ebv |
| EP4052705A1 (en) | 2021-03-05 | 2022-09-07 | Universität Basel Vizerektorat Forschung | Compositions for the treatment of ebv associated diseases or conditions |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5677A (en) | 1848-07-25 | Improvement in hillside-plows | ||
| US171A (en) | 1837-04-20 | Machine for washing iron and other ores | ||
| US4968A (en) | 1847-02-13 | Spinal elevator | ||
| US603A (en) | 1838-02-15 | Improvement in the construction of many-chambered fire-arms | ||
| US5821A (en) | 1848-10-03 | Cream-freezer | ||
| US337A (en) | 1837-07-31 | Mode of constructing railroad-frogs | ||
| US6066322A (en) | 1995-03-03 | 2000-05-23 | Millennium Pharmaceuticals, Inc. | Methods for the treatment of immune disorders |
| US6395876B1 (en) | 1997-12-05 | 2002-05-28 | Medical College Of Georgia Research Institute, Inc. | High-affinity tryptophan transporter |
| SI1270595T1 (sl) | 2000-03-03 | 2008-12-31 | Kyowa Hakko Kogyo Kk | Protitelo proti CCR4 in njegov fragment |
| CN100430420C (zh) | 2001-08-31 | 2008-11-05 | 协和发酵工业株式会社 | 人cdr-移植抗体及其抗体片段 |
| JP4694128B2 (ja) | 2002-01-30 | 2011-06-08 | ザ ブライハム アンド ウイメンズ ホスピタル， インコーポレイテッド | ＴＩＭ−３、Ｔｈ１特異的細胞表面分子に関連した組成物および方法 |
| WO2005057341A2 (en) | 2003-12-02 | 2005-06-23 | Koolspan, Inc. | Automatic hardware-enabled virtual private network system |
| DK1879573T3 (da) | 2005-05-10 | 2013-02-25 | Incyte Corp | Modulatorer af indolamin 2,3-dioxygenase og fremgangsmåder til anvendelse deraf |
| CA2682382A1 (en) * | 2007-03-28 | 2008-10-09 | Biogen Idec Inc. | Non-fucosylated antibodies |
| CA2711370C (en) | 2008-01-15 | 2017-06-13 | The Board Of Trustees Of The Leland Stanford Junior University | Markers of acute myeloid leukemia stem cells |
| CA3012229C (en) * | 2008-07-08 | 2020-11-10 | Incyte Holdings Corporation | 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| WO2010053182A1 (ja) | 2008-11-10 | 2010-05-14 | 協和発酵キリン株式会社 | キヌレニン産生抑制剤 |
| ES2550639T3 (es) * | 2009-04-27 | 2015-11-11 | Kyowa Hakko Kirin Co., Ltd. | Anticuerpo anti-IL-3Ralfa para su utilización en el tratamiento de un tumor de la sangre |
| EP2476438B1 (en) | 2009-09-10 | 2014-07-23 | Kyowa Hakko Kirin Co., Ltd. | Medicament including antibody composition specifically bound to human cc chemokine receptor 4 (ccr4) |
| WO2011042065A1 (en) | 2009-10-09 | 2011-04-14 | Daniel Monsch | "momoheli" lifting module and vehicles |
| TWI535442B (zh) * | 2010-05-10 | 2016-06-01 | Kyowa Hakko Kirin Co Ltd | A nitrogen-containing heterocyclic compound having an action of inhibiting the production of canine erythritine |
| CN103079644B (zh) * | 2010-06-11 | 2017-02-15 | 协和发酵麒麟株式会社 | 抗tim‑3抗体 |
| ES2903205T3 (es) | 2011-11-09 | 2022-03-31 | Kyowa Kirin Co Ltd | Compuestos heterocíclicos que contienen nitrógeno |
| CN104884617B (zh) * | 2012-12-07 | 2019-02-19 | 协和发酵麒麟株式会社 | 抗folr1抗体 |
| JP6603649B2 (ja) * | 2013-03-14 | 2019-11-06 | キュラデブ ファーマ プライベート リミテッド | キヌレニン経路の阻害剤 |
| CN105473550B (zh) | 2013-07-01 | 2019-02-15 | 百时美施贵宝公司 | Ido抑制剂 |
| EP3744715A1 (en) * | 2013-11-08 | 2020-12-02 | Incyte Holdings Corporation | Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitor |
| US20170247449A1 (en) | 2014-06-06 | 2017-08-31 | Kyowa Hakko Kirin Co., Ltd | Therapeutic method and medicament for cancer patients by folr1-targeting drug and an antagonist for folic acid metabolism |
-
2016
- 2016-07-14 US US15/744,322 patent/US20180271861A1/en not_active Abandoned
- 2016-07-14 EP EP21199914.9A patent/EP3991749A3/en active Pending
- 2016-07-14 KR KR1020187001434A patent/KR102823683B1/ko active Active
- 2016-07-14 CA CA2992238A patent/CA2992238A1/en active Pending
- 2016-07-14 AU AU2016293667A patent/AU2016293667A1/en not_active Abandoned
- 2016-07-14 EP EP16824090.1A patent/EP3322444A4/en not_active Withdrawn
- 2016-07-14 JP JP2018500814A patent/JP2018524361A/ja not_active Ceased
- 2016-07-14 WO PCT/JP2016/003337 patent/WO2017010106A1/en not_active Ceased
- 2016-07-14 CN CN201680041307.3A patent/CN107847597A/zh active Pending
- 2016-07-14 TW TW105122337A patent/TW201713332A/zh unknown
- 2016-07-14 HK HK18111823.0A patent/HK1252514A1/zh unknown
-
2021
- 2021-09-01 JP JP2021142739A patent/JP7366093B2/ja active Active
- 2021-11-05 US US17/519,990 patent/US20220088011A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108025051B (zh) | 包含抗pd-1抗体分子的联合疗法 | |
| JP2023039448A (ja) | がんを治療するための、ｐｄ－１アンタゴニスト及びｖｅｇｆｒ／ｆｇｆｒ／ｒｅｔチロシンキナーゼ阻害剤の組合せ | |
| JP6877339B2 (ja) | Ｐｄ−ｌ１に対する抗体分子およびその使用 | |
| KR102833068B1 (ko) | Pd-1에 대한 항체 분자 및 그의 용도 | |
| KR20200089286A (ko) | 조합 요법 | |
| RU2019138337A (ru) | Конъюгаты на основе антитела, содержащие агонист toll-подобного рецептора, и виды комбинированной терапии | |
| JP2019506403A5 (enExample) | ||
| JP7402691B2 (ja) | 抗ｃｄ２５抗体薬物複合体による併用療法 | |
| EP3303399A1 (en) | Methods of treating cancer using anti-ox40 antibodies | |
| JP2019501151A5 (enExample) | ||
| KR20160108568A (ko) | 암을 치료하기 위한 pd-1 길항제 및 ido1 억제제의 조합 | |
| JP2023531676A (ja) | ３－（１－オキソイソインドリン－２－イル）ピぺリジン－２，６－ジオン誘導体を含む投与レジメン | |
| CN105451770A (zh) | 使用PD-1拮抗剂和dinaciclib的组合治疗癌症 | |
| CN105960415A (zh) | 用于治疗癌症的pd-1拮抗剂和vegfr抑制剂的组合 | |
| JP2023500575A (ja) | 癌を治療するためのＰＤ－１アンタゴニスト、ＶＥＧＦＲ／ＦＧＦＲ／ＲＥＴチロシンキナーゼ阻害剤、及びＣＢＰ／β－カテニン阻害剤の組合せ | |
| AU2018328015A1 (en) | Compounds for reducing the viscosity of biological formulations | |
| JP2019517485A5 (enExample) | ||
| JP2020522543A5 (enExample) | ||
| JP2022530241A (ja) | Ｃｄｋ阻害剤と組み合わせたｒａｎｋ経路阻害剤 | |
| JP2022534889A (ja) | Ｃｄｋ阻害剤を使用した組合せ療法 | |
| JP2025156341A (ja) | ＰＤ－１アンタゴニスト、ＨＩＦ－２α阻害剤およびレンバチニブまたはその薬学的に許容され得る塩の組み合わせを使用して、癌またはフォンヒッペル・リンダウ病を処置するための方法 | |
| JP2024521696A (ja) | 併用治療のためのがん患者を同定するための方法 | |
| US10064939B2 (en) | Combination therapy using c-Met inhibitor and IGF-1R inhibitor for c-Met inhibitor resistant cancers | |
| TW202313033A (zh) | 組合療法 | |
| CA3220380A1 (en) | Combination treatment of cancer |